GENE ONLINE|News &
Opinion
Blog

2021-11-15|

9 Leading Molecular Diagnostics Companies to Watch in Taiwan

by Joy Lin
Share To
Molecular diagnosis is a pillar of precision medicine. Capable of predicting treatment effects through a comprehensive analysis of the patient's condition, the approach allows optimal drug selection to slash time and cost for recovery.

Furthermore, periodic screening for biomarkers could detect disease in the early stages, giving much-needed time for prompt treatment that could improve the survival rate of patients. And more importantly, accurate screening helps clinical drug development. These advantages prove how important molecular diagnostics are to modern society.

Taiwan is highly active in the area of in-vitro diagnostics research and development, having launched numerous tests for the world's most popular diseases. In this article, we list 9 companies that will give a quick snapshot of the island's molecular diagnostics industry.

GO Prime with only $1.49 now

LATEST
ASCGT Meeting Navigates Biotech Downturn After Multi-Year Slump
2025-05-14
Seasonal Skin Irritations Rise, Driving Demand for Accessible and Easy-to-Use Treatments
2025-05-14
Tirzepatide Users See 20.2% Average Weight Loss in Obesity Management Trial
2025-05-14
iMMagine-1 Phase 2 Study Provides Data on Investigational Matter Characteristics and Behavior
2025-05-14
Novo Nordisk Partners with Septerna in $2.2 Billion Deal to Develop Oral Obesity Drugs
2025-05-14
SMA: Researchers Explore In Utero Treatment Methods to Mitigate Muscle Weakness Before Birth
2025-05-14
Emrelis Approved for Advanced NSCLC Patients with High c-Met Overexpression
2025-05-14
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top